CoChat
Sign Up
Cited by 302Neurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology StudiesSubstance Abuse Treatment and Outcomes

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Expectation Enhances the Regional Brain Metabolic and the Reinforcing Effects of Stimulants in Cocaine Abusers

Open access
Volkow, Nora D., Wang, Gene-Jack, Ma, Yemin, Fowler, Joanna S., Zhu, Wei, Maynard, Laurence, Telang, Frank, Vaska, Paul, Ding, Yu-Shin, Wong, Christopher, Swanson, James M.·2003·The Journal of Neuroscience
DOI 10.1523/jneurosci.23-36-11461.2003PMC PMC6740524
Open this paper in CoChat — free accountOpen PDF

Abstract

The reinforcing effects of drugs of abuse result from the complex interaction between pharmacological effects and conditioned responses. Here we evaluate how expectation affects the response to the stimulant drug methylphenidate in 25 cocaine abusers. The effects of methylphenidate (0.5 mg/kg, i.v.) on brain glucose metabolism (measured by [18 F]deoxyglucose-positron emission tomography) and on its reinforcing effects (self-reports of drug effects) were evaluated in four conditions: (1) expecting placebo and receiving placebo; (2) expecting placebo and receiving methylphenidate; (3) expecting methylphenidate and receiving methylphenidate; (4) expecting methylphenidate and receiving placebo. Methylphenidate increased brain glucose metabolism, and the largest changes were in cerebellum, occipital cortex, and thalamus. The increases in metabolism were ∼50% larger when methylphenidate was expected than when it was not, and these differences were significant in cerebellum (vermis) and thalamus. In contrast, unexpected methylphenidate induced greater increases in left lateral orbitofrontal cortex than when it was expected. Methylphenidate-induced increases in self-reports of “high” were also ∼50% greater when subjects expected to receive it than when they did not and were significantly correlated with the metabolic increases in thalamus but not in cerebellum. These findings provide evidence that expectation amplifies the effects of methylphenidate in brain and its reinforcing effects. They also suggest that the thalamus, a region involved with conditioned responses, may mediate the enhancement of the reinforcing effects of methylphenidate by expectation and that the orbitofrontal cortex mediates the response to unexpected reinforcement. The enhanced cerebellar activation with expectation may reflect conditioned responses that are not linked to conscious responses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.23-36-11461.2003

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Brain metabolic images at the thalamic and cerebellar levels for the four conditions: (1) expected placebo received placebo, (2) expected placebo received MP, (3) expected MPreceived MP, and (4) expected MP received placebo. Scale is to the right and reflects micromoles/100 gm per minute. Note the larger increases in metabolism when MP was expected than when it was not expected.
Figure 1 Brain metabolic images at the thalamic and cerebellar levels for the four conditions: (1) expected placebo received placebo, (2) expected placebo received MP, (3) expected MPreceived MP, and (4) expected MP received placebo. Scale is to the right and reflects micromoles/100 gm per minute. Note the larger increases in metabolism when MP was expected than when it was not expected.CC-BY-NC-SA · From the PDF
Figure2 Brain maps obtained with SPM after normalization for the global metabolic increases to reveal the areas where MP induced the largest increases in metabolism both for unexpected and expected MP (areas in red). Comparisons are with the 'expected placebo received placebo' condition, and significance was set at p < 0.005. Note that the largest increases with MP occurred in cerebellum, occipital cortex, and thalamus. Note also the much larger areas of activation in thalamus for expected MP and in lateral orbitofrontal cortex for unexpected MP.
Figure2 Brain maps obtained with SPM after normalization for the global metabolic increases to reveal the areas where MP induced the largest increases in metabolism both for unexpected and expected MP (areas in red). Comparisons are with the 'expected placebo received placebo' condition, and significance was set at p < 0.005. Note that the largest increases with MP occurred in cerebellum, occipital cortex, and thalamus. Note also the much larger areas of activation in thalamus for expected MP and in lateral orbitofrontal cortex for unexpected MP.CC-BY-NC-SA · From the PDF
Figure 3 Brain maps obtained with SPM after normalization for the global metabolic increases to reveal the areas where MP induced relative decreases in metabolism for both unexpected and expected MP (areas in blue). Comparisons are with the expected placebo received placebo condition, and significance was set at p < 0.005. Note the relative decreases for both conditions in limbic regions (NAc, Brodmann area 25, insula, amygdala) and in motor cortices.
Figure 3 Brain maps obtained with SPM after normalization for the global metabolic increases to reveal the areas where MP induced relative decreases in metabolism for both unexpected and expected MP (areas in blue). Comparisons are with the expected placebo received placebo condition, and significance was set at p < 0.005. Note the relative decreases for both conditions in limbic regions (NAc, Brodmann area 25, insula, amygdala) and in motor cortices.CC-BY-NC-SA · From the PDF
Figure4 A , Brain maps obtained with SPM showingtheareaswheretheincreasesweresignificantlylargerforexpectedversus unexpected MP (areas in red) and where they were significantly smaller for expected than unexpected MP (areas in blue). Significance was set at p < 0.005. B , Volumes of the areas of activation (number of pixels where activation was at the p < 0.005 level) for thalamus, vermis, and Brodmann area 47 for unexpected and expected MP. The volumes were significantly larger for expected MP in thalamus ( p < 0.001) and vermis ( p < 0.05) and for unexpected MP in Brodmann area 47 ( p < 0.002). The numbers within the parentheses correspond to the total number of pixels for each region and were used to establish the scale in the ordinate axis.
Figure4 A , Brain maps obtained with SPM showingtheareaswheretheincreasesweresignificantlylargerforexpectedversus unexpected MP (areas in red) and where they were significantly smaller for expected than unexpected MP (areas in blue). Significance was set at p < 0.005. B , Volumes of the areas of activation (number of pixels where activation was at the p < 0.005 level) for thalamus, vermis, and Brodmann area 47 for unexpected and expected MP. The volumes were significantly larger for expected MP in thalamus ( p < 0.001) and vermis ( p < 0.05) and for unexpected MP in Brodmann area 47 ( p < 0.002). The numbers within the parentheses correspond to the total number of pixels for each region and were used to establish the scale in the ordinate axis.CC-BY-NC-SA · From the PDF
Figure 5 A , Self-reports of drug effects. MP (unexpected and expected) significantly increased self-report of high (repeated measures ANOVA; F = 32; p < 0.0001), drug liking ( F = 34; p < 0.0001), feel drug ( F = 26; p < 0.0001), and restlessness ( F = 4; p < 0.05). Asterisk indicates significant differences ( p < 0.05) between MP when unexpected (PL/MP) versus when expected (MP/MP). B , Correlations between the changes in metabolism in thalamus and the increases in self-reports of high and drug liking after unexpected and expected MP.
Figure 5 A , Self-reports of drug effects. MP (unexpected and expected) significantly increased self-report of high (repeated measures ANOVA; F = 32; p < 0.0001), drug liking ( F = 34; p < 0.0001), feel drug ( F = 26; p < 0.0001), and restlessness ( F = 4; p < 0.05). Asterisk indicates significant differences ( p < 0.05) between MP when unexpected (PL/MP) versus when expected (MP/MP). B , Correlations between the changes in metabolism in thalamus and the increases in self-reports of high and drug liking after unexpected and expected MP.CC-BY-NC-SA · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 6

  1. 2001, J Nucl Med, 42, 535
  2. Dirckx, SG, Risinger RC, Ross TJ, Li Z, Li SJ, Stein EA 2003 Comparing iv methylphenidate and cocaine in the human brain using fMRI. 9th International Conference on Functional Mapping of the Human Brain, New York, June.
  3. 1997, Arch Ital Biol, 135, 369
  4. 1995, Cereb Cortex, 2, 95
  5. 1999, Life Sci, 65, 7
  6. 1992, Radiology, 186, 59

Cited by

Sorted by citations

Items 201–300 of 302

Related

See all

Metadata

Authors
Volkow, N. D., Wang, G.-J., Ma, Y., Fowler, J. S., Zhu, W., Maynard, L., Telang, F., Vaska, P., Ding, Y.-S., Wong, C., & Swanson, J. M.
Affiliations
State University of New York (US)
ORCID
Venue
The Journal of Neuroscience
Publisher
Society for Neuroscience
Published
2003-12-10
Volume
23
Issue
36
Pages
11461-11468
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
DOI
10.1523/jneurosci.23-36-11461.2003
PMC
PMC6740524
OpenAlex
W1498104517
Cited by
302
References
48
Citations by year
2025: 1 · 2024: 2 · 2023: 12 · 2022: 9 · 2021: 6 · 2020: 5 · 2019: 14 · 2018: 8 · 2017: 11 · 2016: 20 · 2015: 12 · 2014: 22 · 2013: 20 · 2012: 14
FWCI
4.75
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Energy
  • National Institute on Drug Abuse (DA 00280, K20DA000280, DA7092-01)
  • Biological and Environmental Research
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
expectations, cocaine abusers, methylphenidate, drug reinforcement, conditioned response, brain glucose metabolism, thalamus, cerebellum, orbitofrontal cortex, stimulants
MeSH terms
Adult, Central Nervous System Stimulants, Brain, Conditioning, Psychological, Female, Glucose, Humans, Male, Methylphenidate, Reinforcement, Psychology, Tomography, Emission-Computed, Cocaine-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review